Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma.
Lei, K., Gu, X., Alvarado, A.G., Du, Y., Luo, S., Ahn, E.H., Kang, S.S., Ji, B., Liu, X., Mao, H., Fu, H., Kornblum, H.I., Jin, L., Li, H., Ye, K.(2020) J Hematol Oncol 13: 141-141
- PubMed: 33087132 
- DOI: https://doi.org/10.1186/s13045-020-00979-y
- Primary Citation of Related Structures:  
6LLC, 6LLX - PubMed Abstract: 
Glioblastoma (GBM) is a universally lethal tumor with frequently overexpressed or mutated epidermal growth factor receptor (EGFR). NADPH quinone oxidoreductase 1 (NQO1) and glutathione-S-transferase Pi 1 (GSTP1) are commonly upregulated in GBM. NQO1 and GSTP1 decrease the formation of reactive oxygen species (ROS), which mediates the oxidative stress and promotes GBM cell proliferation ...